ITGR logo

INTEGER HOLDINGS CORP

ITGRNYSE
πŸ† #1442 by market capEarnings Oct 22US Equity
$704.82β–² $6.77 (+0.96%)
Simulated price
πŸ””
Track ITGR
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 1.0%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$4.29B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+7.6%
Slowing
πŸ“ŠGross Margin
23.7%
Moderate
πŸ’΅FCF Margin
6.1%
Moderate
βš–οΈP/S Ratio
2.3x
Cheap
Otter Score
76
Good
No chart data available for ITGR.

Trading Snapshot

Day Range
$700.58 – $711.16
52-Week Range
$62.00 – $126.80
Volume
$3.82B
Avg Volume
$3.02B
Shares Outstanding
34.0M
Next Earnings
Nov 1, 2026

Fundamentals Snapshot

Annual Revenue
$1.85B
Last Q Revenue
$464M
P/E Ratio
34.2
P/S Ratio
2.3x
EPS (TTM)
$3.78
Dividend Yield
0.00%
Dilution (1yr)
βˆ’3.0%

Why Investors Own ITGR

  • βœ“High-growth profile β€” revenue up +36.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 26% gross margin and 7% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ITGR logo

INTEGER HOLDINGS CORP

ITGR
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1.8Bβ–² +7.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
23.1%β–Ό βˆ’14.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$209Mβ–² +0.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$105Mβ–² +5.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
35.1Mβ–Ό βˆ’3.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$1.4Bβ–Ό βˆ’$326M YoY
StockOtter Β· stockotter.space

About INTEGER HOLDINGS CORP

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
76/100

Analyst Price Target

β“˜
Average Target
$783.89
β–² +11.2% Upside
High Target$881.50
Low Target$612.12
Based on 11 analysts

Latest News & Updates